End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
1,14,700 KRW | +3.71% | +2.59% | -8.61% |
20/05 | Gc Biopharma and Novel Pharma Announce Sanfilippo Syndrome Treatment Obtains FDA IND Approval | CI |
16/05 | GC Biopharma Corp. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
End-of-day quotes
Sector Other Pharmaceuticals
Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
---|---|---|---|---|---|---|
95Cr | ||||||
74TCr | ||||||
60TCr | ||||||
35TCr | ||||||
32TCr | ||||||
28TCr |